Melincoff Gwen A is a director of Protalix BioTherapeutics Inc.
Person profile
Roles
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
COLLEGIUM PHARMACEUTICAL, INC
16 May 24
4
Protalix BioTherapeutics, Inc.
3 Oct 23
4
Gain Therapeutics, Inc.
26 Jun 23
4
SOLENO THERAPEUTICS INC
26 May 23
4
COLLEGIUM PHARMACEUTICAL, INC
19 May 23
4
SOLENO THERAPEUTICS INC
14 Oct 22
4
SOLENO THERAPEUTICS INC
14 Oct 22
4
Gain Therapeutics, Inc.
22 Sep 22
4
Protalix BioTherapeutics, Inc.
9 Sep 22
4
COLLEGIUM PHARMACEUTICAL, INC
23 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 7,693 | 0.00 | 52,468 |
29 Sep 23 | PLX Protalix BioTherapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 1.66 | 61,676 | 102.38 k | 61,676 |
23 Jun 23 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.5 | 10,500 | 47.25 k | 10,500 |
26 May 23 | SLNO Soleno Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 5.25 | 10,000 | 52.50 k | 10,000 |
25 May 23 | SLNO Soleno Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 5.03 | 2,666 | 13.41 k | 2,666 |
18 May 23 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 9,792 | 0.00 | 44,775 |